M.D., University of Virginia, 1994 M.H.S., Johns Hopkins Bloomberg School of Public Health, 2000
Dept of Med – Endocrinology Welch Center for Prevention, Epidemiology, and Clinical Research Dept of Epi-Bloomberg School of Public Health
2024 E. Monument Street Suite 2-600 Baltimore, MD 21205
sahill@jhmi.edu (410)-502-0993 (410)-955-0476 Dr. Golden's primary research interest centers around identifying endocrine risk factors associated with the development of diabetes and cardiovascular disease through the incorporation of measures of hormonal function into the design of clinical trials of cardiovascular risk modification, observational studies of incident cardiovascular disease and diabetes, and studies evaluating diabetic complications. Her research has used the tools of observational epidemiology to identify endocrine risk factors associated with adverse metabolic outcomes and it has focused on two areas: (1) the hormones of the hypothalamic‑pituitary‑gonadal axis (sex hormones) and (2) the hormones of the hypothalamic‑pituitary‑adrenal (HPA) axis (cortisol). She is also interested in evaluating the hormonal response to chronic stress as a predictor of diabetes and cardiovascular disease. Epidemiology, diabetes, cardiovascular disease, endocrine, cortisol, stress 1997-2007 American Board of Internal Medicine 2001-2010 Diplomate, Endocrinology and Metabolism, American Board of Internal Medicine 1990 Phi Beta Kappa Outstanding Senior Initiate 1990 Phi Kappa Phi National Graduate Fellowship 1990 Sally Sterling Byrd Citizenship Award, Outstanding Senior Female 1990 Mary McLeod Bethune Citizenship Award, Outstanding Minority Student 1990 Summa cum laude, General Honors, High Honors in Biology, University of Maryland, College Park 1993 Alpha Omega Alpha, University of Virginia School of Medicine 1993 C. Richard Bowman Scholarship Recipient, University of Virginia School of Medicine 2000 Delta Omega Honorary Public Health Society 2000 Robert Wood Johnson Minority Medical Faculty Development Program Fellowship 2001 Clinical Research Junior Faculty Award, Second Place, Department of Medicine Research Retreat 1. Kaslow, D. C. and Hill, S. A. “Cloning Metabolic Pathway Genes by Complementation in Eschericia coli: Isolation and Expression of Plasmodium falciparum Glucose Phosphate Isomerase.” Journal of Biological Chemistry 1990; 265(21):12337-12341. 2. Fryburg, D., Jahn, L., Hill, S. Oliveras, D., and Barrett, E. “Insulin and IGF-1 Enhance Human Skeletal Muscle Protein Anabolism During Hyperaminoacidemia by Different Mechanisms.” Journal of Clinical Investigation 1995; 96:1722-1729. 3. Golden, S., Peart-Vigilance, C., Kao, L., Brancati, F. Peri-Operative Glycemic Control and the Risk of Infectious Complications in a Cohort of Adults with Diabetes Mellitus. Diabetes Care 1999;22(9):1408-1414. 4. Liu, Y., Ding, J., Bush, T., Longenecker, C., Nieto, F., Golden, S., Szklo, M. A Hypothesized Relationship between Relative Androgen Excess and Increased Cardiovascular Risk after Menopause. American Journal of Epidemiology 2001;154:489-494. 5. Golden, S. H., Maguire, A., Ding, J., Crouse, J. R., Cauley, J. A., Zacur, H., Szklo, M. Endogenous Post-menopausal Hormones and Carotid Atherosclerosis: A Case-Control Study of the Atherosclerosis Risk in Communities Cohort. American Journal of Epidemiology 2002; 155:437-445. 6. Golden, S. H., Folsom A. R., Coresh, J., Sharrett, A. R., Szklo, M., Brancati, F. L. Risk Factor Clusters Related to Insulin Resistance and Their Synergistic Effects on Subclinical Atherosclerosis: The Atherosclerosis Risk In Communities Study. Diabetes, 2002; 51:3069-3076. 7. Golden, S. H., Wang, N., Brancati, F. L, Meoni, L. A., Klag, M. J. Blood Pressure in Young Adulthood and the Risk of Diabetes Mellitus in Middle Age. Diabetes Care, 2003; 26:1110-1115. 8. Saydah S. H., Brancati F. L., Golden S. H., Fradkin J., Harris M.I.. Depressive Symptoms and the risk of type 2 diabetes mellitus in a US sample. Diabetes/Metabolism Research and Reviews 2003; 19(3): 202-208. 9. Carnethon M. R., Golden, S. H., Folsom A. R., Haskell W., Heiss G., Liao D. A Prospective Investigation of Autonomic Nervous System Function and the Development of Type 2 Diabetes: The Atherosclerosis Risk in Communities Study, 1987-1998. Circulation, 2003; 107:2190-2195. 10. Pankow JS, Duncan BB, Schmidt. MI, Ballantyne CM, Couper DJ, Hoogeveen RC, Golden SH. Fasting Plasma Free Fatty Acids and Risk of Type 2 Diabetes: The ARIC Study. Diabetes Care, 2004; 27:77-82.11. Golden, S. H., Williams J. C., Ford, D. E., Yeh, H., Sanford C., Nieto J., Brancati F. L. Depressive Symptoms and the Risk of Type 2 Diabetes Mellitus: The Atherosclerosis Risk in Communities Study. Diabetes Care, 2004; 27:429-435. 12. Selvin, E., Marinopoulos, S., Berkenblit, G., Rami, T., Brancati, F. L., Powe, N., Golden, S. H. Meta-analysis: Glycated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus. Annals of Internal Medicine, 2004; 141(6):421-431. 13. Golden, S. H., Ding, J., Szklo, M., Inez-Schmidt, M., Duncan, B., Dobs, A. Glucose and Insulin Components of the Metabolic Syndrome are Associated with Hyperandrogenism in Post-menopausal Women: The Atherosclerosis Risk In Communities Study. American Journal of Epidemiology, 2004; 160:540-548. 14. Wong TY, Duncan BB, Golden SH, Klein R, Couper DJ, Klein BEK, Hubbard LD, Sharrett AR, Schmidt MI. Retinal Microvascular Signs and the Metabolic Syndrome: The Atherosclerosis Risk in Communities Study. Investigative Ophthalmology and Visual Science, 2004; 45:2949-2954. 15. McNeill A, Rosamond WD, Girman CJ, Heiss G, Golden SH, Duncan BB, East HE, Ballantyne C. Prevalence of Coronary Heart Disease and Carotid Arterial Thickening in Patients with the Metabolic Syndrome, the ARIC Study. American Journal of Cardiology, 2004; 94:1249-1254. 16. McNeill A, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G. The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study. Diabetes Care, 2005; 28:385-390. 17. Mudali S, Dobs AS, Ding J, Cauley JA, Szklo M, Golden SH. Endogenous Post-menopausal Hormones and Serum Lipids: The Atherosclerosis Risk in Communities Study. Journal of Clinical Endocrinology and Metabolism, 2005; 90:1202-1209. 18. Price EG, Gozu A, Kern DE, Powe NR, Wand GS, Golden S, Cooper LA. The Role of Cultural Diversity Climate in Recruitment, Promotion and Retention of Faculty in Academic Medicine. Journal of General Internal Medicine, 2005; 20:565-571. 19. Selvin E, Coresh J, Golden SH, Boland L, Brancati FL, Steffes, MW. Glycemic Control (HbA1c), Atherosclerosis, and Risk Factors for Cardiovascular Disease in Persons with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care, 2005; 28:1965-1973. 20. Selvin E, Coresh J, Golden SH, Brancati FL, Folsom AR, Steffes MW. Glycemic Control and Coronary Heart Disease Risk in Persons with and without Diabetes: The Atherosclerosis Risk in Communities Study. Archives of Internal Medicine, 2005, In press. 21. Schmidt MI, Duncan BB, Bang H, Pankow J, Ballantyne C, Golden S, Folsom A, Chambless L. Predicting High Risk for the Development of Diabetes—The Atherosclerosis Risk in Communities Study. Diabetes Care, 2005, In press. 22. Golden SH, Hill-Briggs F, Williams K, Stolka K, Mayer RS. Management of Diabetes During Acute Stroke and Inpatient Stroke Rehabilitation. Archives of Physical Medicine and Rehabilitation, 2005, In press. 23. Golden SH, Williams JC, Ford DE, Yeh H, Sanford C, Nieto J, Brancati FL. Anger Temperament is Modestly Associated with the Risk of Type 2 Diabetes Mellitus: The Atherosclerosis Risk in Communities Study. Psychoneuroendocrinology, 2005, In press. 1. Golden, S. H., Wang, N., Brancati, F. L, Meoni, L. A., Klag, M. J. Blood Pressure in Young Adulthood and the Risk of Diabetes Mellitus in Middle Age. Diabetes 2001; 50 (suppl 2):A213 (abstract #873-P). (Presented at the 61st Scientific Sessions of the American Diabetes Association, Philadelphia, PA, June 2001). 2. Golden, S. H., Ford, D. E., Williams J. C., Nieto J., Sanford C., Brancati F. L. Vital Exhaustion and the Risk of Type 2 Diabetes Mellitus: The Atherosclerosis Risk in Communities Study. Diabetes 2002; 51(suppl 2):A226 (abstract #915-P). (Presented as a poster presentation at the 62nd Scientific Sessions of the American Diabetes Association, San Francisco, CA). 3. Saydah S., Golden S. H., Brancati F. L., Byrd-Holt D., Harris M. Depression and Risk of Type 2 Diabetes Mellitus in the U. S. Diabetes 2002; 51 (suppl 2):A65 (abstract #263-OR). (Presented as an oral presentation at the 62nd Scientific Sessions of the American Diabetes Association, San Francisco, CA). 4. Golden, S. H., Ding, J., Szklo, M., Inez-Schmidt, M., Duncan, B., Dobs, A. Hyperandrogenism and the Metabolic Syndrome in Post-menopausal Women: The ARIC Study. (Presented as a poster presentation at the 43rd Annual Conference on Cardiovascular Disease Epidemiology and Prevention, Miami, FL). 5. Carnethon M. R., Folsom, A. R., Golden, S. H., Haskell, W., Heiss G., Liao D. Autonomic Nervous System Function and Incident Diabetes. (Presented as a poster presentation at the 43rd Annual Conference on Cardiovascular Disease Epidemiology and Prevention, Miami, FL). 6. Selvin, E., Marinopoulos, S., Berkenblit, G., Rami, T., Brancati, F. L., Powe, N., Golden, S. H. Glycated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus: A Systematic Review (Presented as a poster presentation at the 63rd Scientific Sessions of the American Diabetes Association, New Orleans, LA.) |